IDiyas

For the Inventor, By the Inventor

New York, NY, United States of America

Dalibor Sames

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 86(Granted Patents)


Company Filing History:

goldMedal11 out of 2,487 
 
Columbia University
 patents
silverMedal4 out of 512 
 
Sloan-kettering Institute for Cancer Research
 patents
bronzeMedal1 out of 45 
 
Research Foundation for Mental Hygiene, Inc.
 patents
4. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12195478 - Opioid receptor modulators (2025-01-14),
2. 11912707 - Mitragynine alkaloids as opioid receptor modulators (2024-02-27),
3. 11840541 - Opioid receptor modulators (2023-12-12),
4. 11787772 - Carboxylic diarythiazepineamines as mixed mu- and delta-opioid receptor agonists (2023-10-17),
5. 11760758 - Mitragynine analogs for the treatment of pain, mood disorders and substance use disorders (2023-09-19),
6. 10961244 - Mitragynine alkaloids as opioid receptor modulators (2021-03-30),
7. 10844027 - Carboxylic diarylthiazepineamines as mu-opioid receptor agonists (2020-11-24),
8. 10183919 - Class of mu-opioid receptor agonists (2019-01-22),
9. 9988377 - Small molecule inducers of GDNF as potential new therapeutics for neuropsychiatric disorders (2018-06-05),
10. 9075014 - pH-responsive fluorescent false neurotransmitters and their use (2015-07-07),
11. 8859615 - Compounds, compositions and methods for reducing toxicity and treating or preventing diseases (2014-10-14),
12. 8337941 - Fluorescent substrates for monoamine transporters as optical false neurotransmitters (2012-12-25),
13. 7550146 - Glycopeptide conjugates and uses thereof (2009-06-23),
14. 7160856 - α-O-linked glycoconjugates, methods of preparation and uses thereof (2007-01-09),
15. 6660714 - &agr;-O-linked glycoconjugates, methods of preparation and uses thereof (2003-12-09),

Title: Dalibor Sames: Innovator in Opioid Receptor Modulation

Introduction

Dalibor Sames is a prominent inventor based in New York, NY, known for his significant contributions to the field of opioid receptor modulation. With a total of 15 patents to his name, Sames has made remarkable strides in developing compounds that address various medical conditions.

Latest Patents

Among his latest patents, Sames has developed compounds that serve as opioid receptor modulators. These inventions include a compound with a specific structure that incorporates various ring structures and substituents. Additionally, he has worked on mitragynine alkaloids as opioid receptor modulators, providing methods for treating pain, depressive disorders, mood disorders, and anxiety disorders through the administration of these compounds.

Career Highlights

Dalibor Sames has had a distinguished career, working with esteemed institutions such as Columbia University and the Sloan Kettering Institute for Cancer Research. His work has significantly impacted the understanding and treatment of pain and related disorders.

Collaborations

Sames has collaborated with notable colleagues, including Andrew Carry Kruegel and Jonathan A. Javitch, further enhancing the scope and impact of his research.

Conclusion

Dalibor Sames continues to be a leading figure in the field of opioid receptor modulation, with his innovative patents paving the way for advancements in medical treatments. His contributions are vital in addressing complex health issues related to pain and mood disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…